← Eichor
Condition: Vocal Cord Disease Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Vocal Cord Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

VoiceS: Voice Quality After Transoral CO2-Laser Surgery Versus Single Vocal Cord Irradiation for Larynx Cancer
NA · 4 location(s) · Olgun Elicin · NCT04057209
Clinical Feasibility & Validation of the Virtual Reality GlenxRose Speech-Language Therapies
NA · 1 location(s) · University of Alberta · NCT05695131
The Use of Dexamethasone in Total Thyroidectomy to Improve Voice Outcome and Hypocalcaemia
Phase 2 · 1 location(s) · Tseung Kwan O Hospital, Hong Kong · NCT05732883
Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia
Phase N/A · 2 location(s) · Zhejiang University · NCT07359586
Detection of Vocal Fold Motion Impairment on Noninvasive Positive Pressure
Phase N/A · 1 location(s) · Nemours Children's Clinic · NCT06406725
Postoperative Vocal Cord Palsy Between Double-lumen Endobronchial Tube and Bronchial Blocker for Robot-assisted Esophage
NA · 1 location(s) · Samsung Medical Center · NCT06897501
Respiratory and Real-time Dynamics in Exercise-Induced Paradoxical Vocal Fold Motion
EARLY_Phase 1 · 1 location(s) · Indiana University · NCT07420530
Characterization of "Bamboo" and Other Vocal Cord Lesions Responsible for Dysphonia in Patients With Systemic Autoimmune
Phase N/A · 1 location(s) · University Hospital, Brest · NCT06779799
"The Voice of Reflux" - Backflow of Gastric Juice Leads to Irritation of the Vocal Folds: Are There Typical Differences
Phase N/A · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT06495606
Effect of Superior Laryngeal Nerve Blocks on Patient Outcomes in Laryngeal Surgery
Phase 2 · 1 location(s) · Rutgers, The State University of New Jersey · NCT06734975
APrevent-VOIS-Implant-002 - a Two-Part, Open-Label, Non-Randomized Multicenter Study
NA · 7 location(s) · APrevent Biotech GmbH · NCT05119842
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.